BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
69.05
-2.34 (-3.28%)
Mar 12, 2026, 3:18 PM EDT - Market open
BridgeBio Pharma Analyst Ratings
Total Analysts
24
Consensus Rating
Strong Buy
Price Target
$83.00
Upside
+20.20%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $89 → $94 | Buy | Maintains | $89 → $94 | +36.13% | Mar 10, 2026 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Mar 10, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $86 → $95 | Strong Buy | Maintains | $86 → $95 | +37.58% | Feb 25, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $83 → $81 | Buy | Maintains | $83 → $81 | +17.31% | Feb 25, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $96 → $98 | Buy | Maintains | $96 → $98 | +41.93% | Feb 25, 2026 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $100 → $125 | Buy | Maintains | $100 → $125 | +81.03% | Feb 25, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $90 → $100 | Strong Buy | Maintains | $90 → $100 | +44.82% | Feb 17, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $81 → $83 | Buy | Maintains | $81 → $83 | +20.20% | Feb 13, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $88 → $98 | Buy | Maintains | $88 → $98 | +41.93% | Feb 13, 2026 |
| Barclays | Barclays | Buy Initiates $80 | Buy | Initiates | $80 | +15.86% | Jan 28, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $84 → $88 | Buy | Maintains | $84 → $88 | +27.44% | Jan 20, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $80 → $86 | Strong Buy | Maintains | $80 → $86 | +24.55% | Jan 8, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $96 | Buy | Initiates | $96 | +39.03% | Jan 6, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $75 → $86 | Buy | Maintains | $75 → $86 | +24.55% | Dec 15, 2025 |
| Bernstein | Bernstein | Buy Initiates $94 | Buy | Initiates | $94 | +36.13% | Dec 11, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $76 → $84 | Buy | Maintains | $76 → $84 | +21.65% | Nov 11, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.